Alembic Pharmaceuticals is a vertically integrated pharmaceutical company that produces generic medicines and active pharmaceutical ingredients.

Alembic Pharmaceuticals

MyAlembic

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

Google Analytics

Google Maps

Finance and Administration

Cecilia Carfora

Sales and Support

Della Lubke

Business Management

Maulik Shah

Sneha Bhongade Wasnik

Sushil Kharkwal

Abhishek Pandey

Aldrin Xavier

Alem Mohite

Amit Mandal

Amit Shimpi

Chirayu Amin

Chairman & CEO

Shaunak Amin

Managing Director

Mr. R. K. Baheti

Director - Finance & CFO

Shivani Patel

Founder & CEO

Ashwaghosh Gaikwad

Division Head - Gynecology Cluster

Pranav Amin

Pharmaceutical Female Founded Companies

Gujarat Companies With More Than 10 Employees (Top 10K)

Pharmaceutical Companies With More Than 1000 Employees

Gujarat Companies With More Than 50 Employees

The legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India. The publicly listed entity that manufactures and markets generic pharmaceutical products across the globe has grown by leaps and bounds over the last century. With an emphasis on innovation and technology, the company has established a state-of-the-art research facility – Alembic Research Centre (ARC)-including formulation research, and 150-bed bioequivalence facility at Vadodara, Gujarat. Additionally, APL has recently invested in ultra-modern R&D center at Hyderabad. APL is one of the leading players in the industry to have invested about 11% of its turnover in R&D. As a growth strategy, the company has aggressively started investing in the international generics market with successful ANDA and DMF filings. APL has also filings across Canada, Europe, Australia, South Africa & Brazil. The company caters to the rest of the world markets through branded formulation sales. The company aims to explore opportunities in the therapeutic areas such as Dermatology, Oncology, and Injectable Formulations. APL also has also co-promoted a company focused on discovery and development of innovative, small molecule drugs that target signal transduction networks and ion channels for the treatment of cancer, inflammation, autoimmune diseases and metabolic disorders.











Medical and Beauty Services and Agricultural Services

Vadodara

Gujarat

India

Asia

Alembic Pharmaceuticals gets USFDA nod for hypertension treatment capsules

Alembic Pharmaceuticals gets USFDA nod for generic hypertension treatment capsules

Indian drugmaker Alembic Pharma misses Q2 profit view as US sales growth slows

Alembic Pharma gets USFDA nod for hypertension treatment drug

Hold Alembic Pharmaceutical; target of Rs 1122: KR Choksey

Just Dial, Alembic Pharmaceuticals and Hatsun Agro Product: Three stocks that outperformed in the week ended July 19

Alembic Pharmaceuticals gets USFDA nod to its generic formulation to treat heart failure

India's Alembic Pharma posts higher Q4 profit on strong N.America sales

Alembic Pharmaceuticals produces a wide range of generic medicines for various therapeutic areas.

Alembic Pharmaceuticals engages in research and development to create new healthcare solutions.

Alembic Pharmaceuticals implements strategies to manage and reduce hazardous and non-hazardous waste generated from its operations.

A healthcare program providing free consultations, medicines, lab tests, and surgeries to communities.

A free clinic offering daily check-ups and specialist consultations to community members.

A project aimed at reducing malnutrition and anemia among women and children in specific villages.

United States

North America

Egypt

Africa

Pakistan

HTML5

Bootstrap

jQuery

Google Maps API

Adobe Flash

Google Drive

Comodo PositiveSSL Certificates

Google Fonts

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Alembic Pharmaceuticals Limited

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 24, 2024 7:14 PM	b0a400d8
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 24, 2024 7:14 PM	c0a5b63a
crunchbase trigger	general	Nov 25, 2024 9:09 AM	56adcec1
crunchbase profile	general	Nov 25, 2024 10:58 AM	7f5dc9f0
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:11 PM	437ae78b
peers	general	Oct 24, 2024 7:14 PM	df0670f8
news basic	general	Oct 24, 2024 7:14 PM	fca782bb
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:ALEMBICPHARMACEUTICALS

Alembic Pharmaceuticals

Last Close

1,041.85

25/11 09:40

Market Cap

196.41B

Beta: -

Volume Today

140.60K

Avg: -